For treatment of severe fractures, stem cells derived from bone marrow could be used to generate new bone tissue. But scientists need better ways to keep the cells alive once they’re implanted. Linda Griffith and colleagues at MIT have created a new tissue-engineering material that could fit the bill. The comblike material consists of a Plexiglas backbone studded with molecular tethers that can attach to a specific kind of growth factor, a protein that helps many cells, including stem cells, grow and differentiate. Adult stem cells grown on these scaffolds (left) were better able to survive and proliferate, potentially increasing the number of cells available to make new bone after transplantation. Scientists are now testing the material in animals. Griffith is planning additional experiments with human stem cells, to explore how tethering different proteins to the scaffold might do a better job of encouraging the cells to differentiate into bone. “We want to figure out, step by step, how to use marrow more effectively in the clinic,” she says.
This scientist now believes covid started in Wuhan’s wet market. Here’s why.
How a veteran virologist found fresh evidence to back up the theory that covid jumped from animals to humans in a notorious Chinese market—rather than emerged from a lab leak.
How Facebook and Google fund global misinformation
The tech giants are paying millions of dollars to the operators of clickbait pages, bankrolling the deterioration of information ecosystems around the world.
We still don’t know enough about the omicron variant to panic
The variant has caused alarm and immediate border shutdowns—but we still don't know how it will respond to vaccines.
NSO was about to sell hacking tools to France. Now it’s in crisis.
French officials were close to buying controversial surveillance tool Pegasus from NSO earlier this year. Now the US has sanctioned the Israeli company, and insiders say it’s on the ropes.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.